POAGX Mutual Fund

NAV$60.75

Fund Essentials - as of Jan 31, 2026

Net Assets
$7.9B
Expense Ratio
0.66%
Dividend Yield (Current)
10.11%
Holdings
179
Inception Date
Nov 1, 2004
Fund Family
PRIMECAP Odyssey Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+28.95%
1 Year+62.16%
3 Year+26.84%
5 Year+12.10%
10 Year+16.30%

Asset Allocation

Stocks: 97.40%
Cash: 1.82%
Other: 0.78%

Top Holdings

View All →
TickerNameWeight
MUMicron Tech9.22%
LLYEli Lilly & Co3.40%
BGNEBeigene, Ltd. (adr)3.26%
RYTMRhythm Pharmaceuticals Inc3.19%
GOOGLAlphabet Inc Common Stock USD 0.0012.72%
Top 10 Concentration: 33.43%Report Date: Jan 31, 2026
Download all 179 holdings for POAGX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.11%
Frequency
Annually
Latest Distribution
$5.85
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

POAGX Mutual Fund Overview

POAGX Mutual Fund (PRIMECAP Odyssey Aggressive Growth Fund) is managed by PRIMECAP Odyssey Funds with $7.95B in net assets. POAGX expense ratio is 0.66%, holding 179 positions across sectors including Information Technology, Health Care, Industrials. Inception date: 2004-11-01.

POAGX performance shows a YTD return of 28.95%. The 1-year return is 62.16% and the 5-year return is 12.10%. POAGX dividend yield stands at 10.11%, paid annually.

POAGX top holdings include Micron Tech (9.2%), Eli Lilly & Co (3.4%), Beigene, Ltd. (adr) (3.3%), Rhythm Pharmaceuticals Inc (3.2%), Alphabet Inc Common Stock USD 0.001 (2.7%). View all POAGX holdings, sector breakdown, or dividend history.

POAGX can be compared against other funds using the overlap calculator or side-by-side comparison tool. POAGX alternatives are available via the screener, along with tax-loss harvesting opportunities.